Fosaprepitant dimeglumine
CAS No. 265121-04-8
Fosaprepitant dimeglumine ( MK 0517 )
产品货号. M13812 CAS No. 265121-04-8
Fosaprepitant dimeglumine(MK-0517) is a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting.
纯度: >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥365 | 有现货 |
|
10MG | ¥494 | 有现货 |
|
25MG | ¥996 | 有现货 |
|
50MG | ¥1806 | 有现货 |
|
100MG | ¥2989 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Fosaprepitant dimeglumine
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Fosaprepitant dimeglumine(MK-0517) is a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting.
-
产品描述Fosaprepitant dimeglumine(MK-0517) is a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting.
-
同义词MK 0517
-
通路GPCR/G Protein
-
靶点Neurokinin Receptor
-
受体NK1
-
研究领域Neurological Disease
-
适应症——
化学信息
-
CAS Number265121-04-8
-
分子量1004.83
-
分子式C37H56F7N6O16P
-
纯度>98%(HPLC)
-
溶解度Water: 135 mg/mL (134.35 mM); DMSO: 201 mg/mL (200.03 mM)
-
SMILESC[C@H](C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)O[C@@H]2[C@@H](N(CCO2)CC3=NC(=O)N(N3)P(=O)(O)O)C4=CC=C(C=C4)F.CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O.CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Navari RM. Expert Opin Investig Drugs, 2007, 16(12), 1977-1985.
产品手册
关联产品
-
[Sar9,Met(O2)11]-Sub...
Sar9, Met (O2)11-Substance P is a neurokinin-1 receptor agonist. It is an analog of the naturally occurring human neuropeptide Substance P, which can be found throughout the body, including in the airways of humans and many other species.
-
Hemokinin 1 (mouse)
Hemokinin 1 (mouse) is a selective excitogen 1 receptor agonist with a Ki value of 0.175 nM for the human NK1 receptor and 560 nM for the human NK2 receptor.
-
Ibodutant
A potent and selective linear tachykinin NK2 receptor antagonist with pKb of 9.3; displays >1,000-fold selectivity over NK1 and NK3 (pKb<6).